`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`LIQUIDIA TECHNOLOGIES, INC.,
`Petitioner
`
`v.
`
`UNITED THERAPEUTICS CORPORATION,
`Patent Owner
`
`
`
`
`Case No. IPR2020-00770
`U.S. Patent No. 9,604,901
`
`
`
`
`PETITIONER’S REQUEST FOR ORAL HEARING
`
`
`
`
`
`
`
`Petitioner’s Request for Oral Hearing
`IPR2020-00770
`
`
`
`Pursuant to 37 C.F.R. § 42.70(a), Petitioner Liquidia Technologies, Inc.,
`
`requests an oral hearing on all grounds of unpatentability raised in this proceeding.
`
`Petitioner also requests oral hearing on any issues raised by Patent Owner in its
`
`Request for Oral Hearing, any procedural or evidentiary issues raised by the parties,
`
`and any additional issues or questions raised by the Board or the parties before or
`
`during the oral argument.
`
`Petitioner requests 60 minutes total to address all the issues involved in this
`
`proceeding. See PTAB Consolidated Trial Practice Guide, Nov. 2019 Ed., 81-82
`
`(“Practice Guide”) (“The Board expects to ordinarily provide for an hour of
`
`argument per side for a single proceeding, but a party may request more or less time
`
`depending on the circumstances of the case.”). To the extent the Board schedules
`
`the hearing to last more than 120 minutes total, however, Petitioner requests that it
`
`should be given half the length of the hearing to address these issues. Petitioner
`
`further requests that it be permitted to speak first at oral argument as the party
`
`bearing the burden of showing the unpatentability of the challenged claims, and that
`
`it be permitted to reserve time for rebuttal following Patent Owner’s allotted
`
`argument time.
`
`
`
`Pursuant to the notice regarding oral hearings occurring after March 13, 2020,
`
`Petitioner requests to participate via remote video and/or telephonically, unless the
`
`1
`
`
`
`Petitioner’s Request for Oral Hearing
`IPR2020-00770
`
`Board or the USPTO notifies otherwise. Petitioner further requests authorization to
`
`present demonstrative slides during oral argument and, to the extent a live hearing
`
`is conducted, the use of audio-visual equipment suitable to display papers of record
`
`and demonstrative exhibits, including a computer-connectable projector, an ELMO,
`
`and a screen.
`
`Petitioner further requests the services of a court reporter to transcribe the
`
`proceeding.
`
`
`Dated: May 3, 2021
`
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue NW
`Suite 700
`Washington, DC 20004
`Tel: (212) 479-6840
`Fax: (212) 479-6275
`
`
`
`
`
`
`
`
`By:
`
`
`
`
`Respectfully submitted,
`
`
`/Ivor R. Elrifi/
`Ivor R. Elrifi
`Reg. No. 39,529
`Counsel for Petitioner
`
`2
`
`
`
`Petitioner’s Request for Oral Hearing
`IPR2020-00770
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. §§42.6(e)(4)(i) et seq., a complete copy of the attached
`PETITIONER’S REQUEST FOR ORAL HEARING, is being served via email
`on the 3rd day of May 2021, upon Patent Owner’s attorneys of record:
`
`UTC-901@foley.com
`Stephen B. Maebius (smaebius@foley.com)
`George Quillin (gquillin@foley.com)
`Daniel R. Shelton (dshelton@foley.com)
`FOLEY & LARDNER LLP
`
`Douglas Carsten (dcarsten@mwe.com)
`April E. Weisbruch (aweisbruch@mwe.com)
`Judy Mohr (jmohr@mwe.com)
`MCDERMOTT WILL & EMERY LLP
`
`Richard Torczon (rtorczon@wsgr.com)
`WILSON, SONSINI, GOODRICH & ROSATI
`
`Shaun R. Snader (ssnader@unither.com)
`UNITED THERAPEUTICS CORP.
`
`
`
`
`By:
`
`
`
`
`
`/Ivor R. Elrifi/
`Ivor R. Elrifi
`Reg. No. 39,529
`Counsel for Petitioner
`
`
`
`Dated: May 3, 2021
`
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue NW
`Suite 700
`Washington, DC 20004
`Tel: (212) 479-6840
`Fax: (212) 479-6275
`
`
`
`
`
`
`
`3
`
`